Osaka, Japan

Mayumi Takano

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mayumi Takano: Innovator in Pharmaceutical Chemistry

Introduction

Mayumi Takano is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. Her work has led to the filing of multiple patents, showcasing her innovative approach to drug discovery.

Latest Patents

Mayumi Takano holds 2 patents related to Tetrahydroquinoline derivatives. These patents describe a novel compound that exhibits inhibitory activity against cholesteryl ester transfer protein (CETP). The compounds are characterized by specific structural formulas, which include various substituents that enhance their pharmacological properties. This innovative work has the potential to impact the treatment of conditions related to lipid metabolism.

Career Highlights

Mayumi Takano is currently employed at Mitsubishi Tanabe Pharma Corporation, where she continues to advance her research in pharmaceutical development. Her expertise in synthesizing complex chemical compounds has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Mayumi has collaborated with notable colleagues, including Hitoshi Kubota and Masakatsu Sugahara. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Mayumi Takano's contributions to pharmaceutical chemistry and her innovative patents reflect her dedication to advancing medical science. Her work not only showcases her talent as an inventor but also highlights the importance of collaboration in achieving significant breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…